First Generic Version of Advair Diskus Approved for Asthma, COPD
THURSDAY, Jan. 31, 2019 -- The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the U.S. Food and Drug Administration.
It can now be used to treat children aged 4 or...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Advair | Advair Diskus | Asthma | Children | Chronic Obstructive Pulmonary | Flonase | Flovent | Food and Drug Administration (FDA) | General Medicine